Breaking News, Collaborations & Alliances

Hongene, ReciBioPharm Partner to Enhance Gene Editing Drug Manufacturing Capabilities

Will create a unique solution for innovators in the gene editing field.

Author Image

By: Charlie Sternberg

Associate Editor

Hongene Biotech Corporation, an expert in nucleic acid manufacturing, and ReciBioPharm, an advanced therapeutics CDMO services provider, have announced a strategic collaboration that aims to enhance gene editing drug manufacturing capabilities.   The strategic alliance between the two companies creates a unique solution for innovators in the gene editing field. ReciBioPharm will expand its service portfolio to include sgRNA manufacturing, utilizing Hongene’s innovative synthesis process, provi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters